Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$13.12 - $15.03 $637,946 - $730,818
-48,624 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$13.54 - $15.35 $486,465 - $551,494
35,928 Added 282.99%
48,624 $696,000
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $167,206 - $208,214
12,696 New
12,696 $173,000
Q3 2021

Nov 15, 2021

SELL
$16.3 - $17.26 $179,560 - $190,136
-11,016 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$16.55 - $18.64 $57,378 - $64,624
-3,467 Reduced 23.94%
11,016 $185,000
Q1 2021

May 17, 2021

SELL
$16.71 - $19.9 $999,341 - $1.19 Million
-59,805 Reduced 80.5%
14,483 $264,000
Q4 2020

Feb 16, 2021

SELL
$15.39 - $18.97 $1.18 Million - $1.45 Million
-76,407 Reduced 50.7%
74,288 $1.35 Billion
Q3 2020

Nov 06, 2020

SELL
$17.1 - $19.19 $479,124 - $537,684
-28,019 Reduced 15.68%
150,695 $2.69 Million
Q2 2020

Aug 04, 2020

SELL
$14.59 - $19.5 $234,913 - $313,969
-16,101 Reduced 8.26%
178,714 $3.2 Million
Q1 2020

May 12, 2020

BUY
$13.02 - $20.31 $940,395 - $1.47 Million
72,227 Added 58.92%
194,815 $2.96 Million
Q4 2019

Feb 04, 2020

BUY
$16.88 - $20.83 $60,666 - $74,863
3,594 Added 3.02%
122,588 $2.42 Million
Q3 2019

Nov 07, 2019

BUY
$16.15 - $17.99 $364,004 - $405,476
22,539 Added 23.37%
118,994 $2.05 Million
Q2 2019

Aug 05, 2019

BUY
$16.58 - $20.49 $275,924 - $340,994
16,642 Added 20.85%
96,455 $1.71 Million
Q1 2019

May 08, 2019

BUY
$16.7 - $21.52 $829,839 - $1.07 Million
49,691 Added 164.97%
79,813 $1.63 Million
Q4 2018

Feb 12, 2019

BUY
$15.64 - $21.1 $471,108 - $635,574
30,122 New
30,122 $507,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.